InvestorsObserver
×
News Home

What is the Market's View on Theravance Biopharma Inc (TBPH) Stock's Price and Volume Trends

Tuesday, January 19, 2021 11:33 AM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Theravance Biopharma Inc (TBPH) Stock's Price and Volume Trends

Theravance Biopharma Inc (TBPH) stock has risen 7.46% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.

Sentiment Score - ,bullish
Theravance Biopharma Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TBPH!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.

InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.

Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With TBPH Stock Today?

Theravance Biopharma Inc (TBPH) stock is trading at $18.00 as of 11:32 AM on Tuesday, Jan 19, an increase of $0.01, or 0.06% from the previous closing price of $17.99. Volume today is below average. So far 150,828 shares have traded compared to average volume of 305,574 shares. The stock has traded between $17.66 and $18.72 so far today.

To see InvestorsObserver's Sentiment Score for Theravance Biopharma Inc click here.

More About Theravance Biopharma Inc

Theravance Biopharma is a diversified biotechnology company that creates medicines to treat serious illnesses. The company's research and development are concentrated primarily on four therapeutic areas-infectious disease, respiratory, gastrointestinal disease, and cardiovascular and renal disease. Its commercial infrastructure is focused primarily on the acute care setting. The company uses strategic collaboration with other industry players. Theravance generates the majority of its revenue in the U.S. and Europe, followed by Asia.

Click Here to get the full Stock Score Report on Theravance Biopharma Inc (TBPH) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App